[New tendencies in combination antihypertensive therapy]

Area of Science:

• Cardiology
• Pharmacology
• Nephrology

Background:

• Hypertension management increasingly requires combination therapy to achieve target blood pressures.
• Diuretics are effective antihypertensives, especially in combination with ACE inhibitors or AT1 blockers.
• Concerns exist regarding long-term diuretic use and risks of kidney failure, diabetes, and cardiovascular events.

Purpose of the Study:

• To evaluate the efficacy and safety of combination antihypertensive treatments.
• To compare amlodipine/perindopril combination with atenolol/bendroflumethiazide.
• To assess the role of diuretics in long-term hypertension management.

Main Methods:

• Comparative study analyzing mortality, cardiovascular events, and stroke risk.
• Review of existing data on diuretic use in hypertension management.
• Reference to the ASCOT study comparing different antihypertensive regimens.

Main Results:

• Amlodipine/perindopril significantly reduced mortality, cardiovascular events, and stroke risk compared to atenolol/bendroflumethiazide.
• Diuretics enhance blood pressure reduction when combined with ACE inhibitors or AT1 blockers.
• The ASCOT study indicated that beta-blocker/diuretic combinations were inferior to calcium antagonist/ACE inhibitor treatments.

Conclusions:

• Combination therapy, such as amlodipine/perindopril, offers significant benefits in hypertension management.
• Long-term diuretic use warrants caution due to potential risks of kidney failure and diabetes.
• Further comparative studies are essential to guide the long-term use of diuretics and newer antihypertensives.